Literature DB >> 6353952

The lymphoid lesions associated with the acquired immunodeficiency syndrome.

H L Ioachim, C W Lerner, M L Tapper.   

Abstract

In the present epidemic of opportunistic infections affecting homosexual men, systemic, persistent, unexplained lymphadenopathies have frequently accompanied and often preceded other manifestations of the acquired immunodeficiency syndrome (AIDS). Studies of the lymphadenopathies associated with AIDS have not yet been published, and the lymph node lesions have been generally considered to represent reactive lymphoid hyperplasia. The present study concerns the lymph node biopsies of 36 homosexual males with systemic, persistent lymphadenopathy. The lesions were essentially uniform and consisted of focal hemorrhages, extreme hyperplasia of germinal centers, extensive cellular destruction, accumulation of neutrophils, phagocytosis of nuclear debris, proliferation of blood vessels, immunoblasts, and peculiar aggregates of clear cells. These lesions diagnosed as acute lymphadenitis accompanied diseases indicative of AIDS in six cases and preceded them by months in three cases. In two cases, the lymphadenitis was associated with Kaposi's sarcoma of lymph node and in two cases with non-Hodgkin's lymphomas. It is suggested that the systemic, persistent lymphadenitis of homosexual males is induced by a microorganism, probably a virus. The lymphotropic activity of such an agent may include the destruction of a certain class of lymphocytes leading to the induction of the acquired immunodeficiency syndrome. Under special, unknown circumstances, the uncontrolled lymph node hyperplasia may progress to the development of lymphoma.

Entities:  

Mesh:

Year:  1983        PMID: 6353952     DOI: 10.1097/00000478-198309000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  Nucleic acid cytometry of homosexual-associated lymphoproliferative disease.

Authors:  J R Srigley; J J Butler; B M Osborne; L Guarda; B Barlogie
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

2.  HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy.

Authors:  P Biberfeld; K J Chayt; L M Marselle; G Biberfeld; R C Gallo; M E Harper
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

3.  Increased frequency of HLA-DR11 in pediatric human immunodeficiency virus-associated parotid gland enlargement.

Authors:  S J Schuval; M E O'Reilly; V R Bonagura
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

4.  Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.

Authors:  M E Harper; L M Marselle; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

5.  The immunohistology of non-T cells in the acquired immunodeficiency syndrome.

Authors:  G S Wood; B F Burns; R F Dorfman; R A Warnke
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

Review 6.  Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues.

Authors:  Jacob D Estes
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

7.  Lymphadenopathy in drug addicts. A study of the distribution of T lymphocyte subsets in the lymph nodes.

Authors:  M F Toccanier; Y Kapanci
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

8.  An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS.

Authors:  G Janossy; A J Pinching; M Bofill; J Weber; J E McLaughlin; M Ornstein; K Ivory; J R Harris; M Favrot; D C Macdonald-Burns
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

9.  Human immunodeficiency virus-infected multinucleated histiocytes in oropharyngeal lymphoid tissues from two asymptomatic patients.

Authors:  A Rinfret; H Latendresse; R Lefebvre; G St-Louis; P Jolicoeur; L Lamarre
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

10.  Effects of chronic topical application of 12-O-tetradecanoylphorbol-13-acetate on the skin and internal organs of SENCAR mice.

Authors:  A J Klein-Szanto; C J Conti; C M Aldaz; N Clapp; S Nesnow; T J Slaga
Journal:  Environ Health Perspect       Date:  1986-09       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.